Under the category “Spiritual companies in Lund”, Skånska Dagbladet has drawn attention to SpectraCure! In an article, Johannes Swartling, CTO, is interviewed, where he tells us more about the company, our method and the ongoing clinical study.
The article can be read here: https://www.skd.se/2023-03-19/solida-tumorer-kan-botas-med-lundametod
SpectraCure is developing the future systems for the treatment of internal solid cancer tumours. The goal of the proprietary and patented treatment system is to eliminate deep-seated cancer tumours and prolong the survival of cancer patients while maintaining their quality of life. When prostate cancer recurs, there are often no established treatment options other than lifelong hormone therapy, with its associated side effects.